Abstract
The photodynamic activity of dibiotinylated aluminum sulfophthalocyanine was studied in vitro and in vivo. Dibiotinylated aluminum sulfophthalocyanine provided enhanced phototoxic action on OAT-75 cell monolayers as compared with the parent drug. Photodynamic therapy of mice with Ehrlich carcinoma using dibiotinylated aluminum sulfophthalocyanine (0.25 mg/kg) resulted in enhanced inhibition of tumor growth, pronounced vascular damage (thrombosis and destruction of vascular walls) and eventual tumor necrosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aluminum / pharmacology*
-
Aluminum / radiation effects*
-
Animals
-
Biotin / analogs & derivatives*
-
Biotin / chemical synthesis
-
Biotin / pharmacology
-
Biotinylation*
-
Carcinoma, Small Cell
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Cell Survival / radiation effects
-
Humans
-
Indoles / chemical synthesis*
-
Indoles / pharmacology*
-
Light
-
Lung Neoplasms
-
Mice
-
Photochemotherapy
-
Photosensitizing Agents / chemical synthesis
-
Photosensitizing Agents / pharmacology*
Substances
-
Indoles
-
Photosensitizing Agents
-
dibiotinylated aluminum sulfophthalocyanine
-
Biotin
-
Aluminum